BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 5, 2010
View Archived Issues
Silver dihydrogen citrate antimicrobial shows preclinical efficacy in fungal infections
Read More
Chinese scientists claim new immunosuppressants
Read More
ArQule presents new FGFR-2 inhibitors
Read More
Spanish scientists discover new merosesquiterpenic derivatives with antitumor activity
Read More
MUSC Foundation for Research Development discloses new sphingosine kinase inhibitors
Read More
Phase I trial evaluates edotecarin plus 5-FU/leucovorin in advanced solid tumors
Read More
Clinical data disclosed on rituximab vs. cyclophosphamide in ANCA-associated vasculitis
Read More
Candesartan inhibits fibrosis in rat model of RMI by suppressing sFRP-2
Read More
Japanese scientists identify potential biomarkers for coronary artery disease
Read More
TM-38837 shows favorable safety and pharmacokinetics in healthy subjects
Read More
CTI files SPA with FDA for phase III pixantrone trial in non-Hodgkin's lymphoma
Read More
Curis identifies new inhibitors of PI3-kinase, mTOR and HDAC
Read More
Access Pharma advances thiarabine in hematological malignancies
Read More
Conditions for approval of Actemra for RA and pJIA lifted in Japan
Read More
ADXS-11-001 to enter phase II trial in cervical cancer in India
Read More
FDA clears Antisense Pharma's IND for trabedersen in high-grade glioma
Read More
EXC-001 reduces scar severity after abdominoplasty surgery in phase II trial
Read More
Idera raises funds to continue developing TLR-targeting agents
Read More
Five Prime and GSK join to discover drugs for skeletal muscle disorders
Read More
Shire subsidiary to acquire Movetis
Read More
Boston Scientific begins enrollment in EVOLVE trial of Synergy stent
Read More
Daiichi Sankyo initiates open offer for Zenotech Laboratories shares
Read More
Boceprevir meets primary endpoints in pivotal phase III trials in hepatitis C
Read More
PerkinElmer acquires VisEn Medical
Read More
Mipomersen lowers LDL-cholesterol in two phase III trials
Read More